pH-Specific structural speciation of the ternary V(V)-peroxido-betaine system: a chemical reactivity-structure correlation.

Vanadium involvement in cellular processes requires deep understanding of the nature and properties of its soluble and bioavailable forms arising in aqueous speciations of binary and ternary systems. In an effort to understand the ternary vanadium-H(2)O(2)-ligand interactions relevant to that metal ion's biological role, synthetic efforts were launched involving the physiological ligands betaine (Me(3)N(+)CH(2)CO(2)(-)) and H(2)O(2). In a pH-specific fashion, V(2)O(5), betaine, and H(2)O(2) reacted and afforded three new, unusual, and unique compounds, consistent with the molecular formulation K(2)[V(2)O(2)(O(2))(4){(CH(3))(3)NCH(2)CO(2))}]·H(2)O (1), (NH(4))(2)[V(2)O(2)(O(2))(4){(CH(3))(3)NCH(2)CO(2))}]·0.75H(2)O (2), and {Na(2)[V(2)O(2)(O(2))(4){(CH(3))(3)NCH(2)CO(2))}(2)]}(n)·4nH(2)O (3). All complexes 1-3 were characterized by elemental analysis; UV/visible, FT-IR, Raman, and NMR spectroscopy in solution and the solid state; cyclic voltammetry; TGA-DTG; and X-ray crystallography. The structures of 1 and 2 reveal the presence of unusual ternary dinuclear vanadium-tetraperoxido-betaine complexes containing [(V(V)═O)(O(2))(2)] units interacting through long V-O bonds. The two V(V) ions are bridged through the oxygen terminal of one of the peroxide groups bound to the vanadium centers. The betaine ligand binds only one of the two V(V) ions. In the case of the third complex 3, the two vanadium centers are not immediate neighbors, with Na(+) ions (a) acting as efficient oxygen anchors and through Na-O bonds holding the two vanadium ions in place and (b) providing for oxygen-containing ligand binding leading to a polymeric lattice. In 1 and 3, interesting 2D (honeycomb) and 1D (zigzag chains) topologies of potassium nine-coordinate polyhedra (1) and sodium octahedra (3), respectively, form. The collective physicochemical properties of the three ternary species 1-3 project the chemical role of the low molecular mass biosubstrate betaine in binding V(V)-diperoxido units, thereby stabilizing a dinuclear V(V)-tetraperoxido dianion. Structural comparisons of the anions in 1-3 with other known dinuclear V(V)-tetraperoxido binary anionic species provide insight into the chemical reactivity of V(V)-diperoxido systems and their potential link to cellular events such as insulin mimesis and anitumorigenicity modulated by the presence of betaine.

[1]  W. Harrison,et al.  Barium Oxalates Combined with Oxo-Anions and Organic Cations: Syntheses and Structures of Ba2(C2O4)(H2PO3)2 and C2H10N2·Ba(H2O)2(HC2O4)4 , 2011 .

[2]  M. Burghammer,et al.  Occurrence of Uncommon Infinite Chains Consisting of Edge-Sharing Octahedra in a Porous Metal Organic Framework-Type Aluminum Pyromellitate Al4(OH)8[C10O8H2] (MIL-120): Synthesis, Structure, and Gas Sorption Properties , 2009 .

[3]  A. Salifoglou,et al.  Aqueous V(V)-peroxo-amino acid chemistry. Synthesis, structural and spectroscopic characterization of unusual ternary dinuclear tetraperoxo vanadium(V)-glycine complexes. , 2009, Inorganic chemistry.

[4]  V. Terskikh,et al.  Practical Aspects of 51V and 93Nb Solid-State NMR Spectroscopy and Applications to Oxide Materials , 2008 .

[5]  A. Salifoglou,et al.  pH-specific synthesis, isolation, spectroscopic and structural characterization of a new dimeric assembly of dinuclear vanadium(V)–citrate–peroxo species from aqueous solutions , 2008 .

[6]  F. Albericio,et al.  Understanding the Mechanism of Action of the Novel SSAO Substrate (C7NH10)6(V10O28)·2H2O, a Prodrug of Peroxovanadate Insulin Mimetics , 2007, Chemical biology & drug design.

[7]  D. Rehder,et al.  Vanadium-51 NMR , 2007 .

[8]  A. Salifoglou,et al.  Synthesis, isolation, spectroscopic and structural characterization of a new pH complex structural variant from the aqueous vanadium(V)-peroxo-citrate ternary system , 2006 .

[9]  J. Marek,et al.  Racemic monoperoxovanadium(V) complexes with achiral OO and ON donor set heteroligands: synthesis, crystal structure and stereochemistry of [NH3(CH2)2NH3][VO(O2)(ox)(pic)].2H2O and [NH3(CH2)2NH3][VO(O2)(ox)(pca)]. , 2005, Dalton transactions.

[10]  D. Rehder Structure and function of vanadium compounds in living organisms , 2005, Biometals.

[11]  P. Schwendt,et al.  Synthesis and characterization of vanadium(V) complexes with α-hydroxyhippuric acid. The X-ray crystal structure of (NBu4)2[V2O2(O2)2(R-α-hhip) (S-α-hhip)]·5H2O,[α-hhip = α-hydroxyhippurato(2-)] , 2004 .

[12]  V. Sergienko Structural chemistry of oxoperoxo complexes of vanadium(V): A review , 2004 .

[13]  J. Marek,et al.  Peroxovanadium(V) complexes of α-hydroxyhippuric acid. The X-ray crystal structure of (N Pr 4 ) 2 [V 2 O 2 (O 2 ) 2 (α-hhip) 2 ]·5H 2 O, [α-hhip=α-hydroxyhippurato (2–)−C 9 H 7 NO 4 (2–)] , 2004 .

[14]  A. Salifoglou,et al.  pH-specific synthesis of a dinuclear vanadium(V)-peroxo-citrate complex in aqueous solutions: pH-dependent linkage, spectroscopic and structural correlations with other aqueous vanadium(V)-peroxo-citrate and non-peroxo species. , 2004, Inorganic chemistry.

[15]  D. Crans,et al.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.

[16]  P. Drake,et al.  Insulin receptor-associated protein tyrosine phosphatase(s): Role in insulin action , 1998, Molecular and Cellular Biochemistry.

[17]  B. Posner,et al.  A stable peroxovanadium compound with insulin-like action in human fat cells , 1996, Diabetologia.

[18]  B. Feringa,et al.  Catalytic oxidations by vanadium complexes , 2003 .

[19]  Santiago Alvarez,et al.  Continuous symmetry maps and shape classification. The case of six-coordinated metal compounds , 2002 .

[20]  Hiromu Sakurai,et al.  Antidiabetic vanadium(IV) and zinc(II) complexes , 2002 .

[21]  H. Sakurai,et al.  Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice. , 2002, Journal of inorganic biochemistry.

[22]  H. Sakurai,et al.  Syntheses, structures, stability, and insulin-like activities of peroxovanadium(V) complexes with a heteroligand. , 2001, Journal of inorganic biochemistry.

[23]  A. Salifoglou,et al.  Systematic synthesis, structural characterization, and reactivity studies of vanadium(V)–citrate anions [VO2(C6H6O7)]22−, isolated from aqueous solutions in the presence of different cations , 2001 .

[24]  J. McNeill,et al.  Insulin-enhancing vanadium(III) complexes. , 2001, Inorganic chemistry.

[25]  A. Salifoglou,et al.  pH-dependent investigations of vanadium(V)-peroxo-malate complexes from aqueous solutions. In search of biologically relevant vanadium(V)-peroxo species. , 2001, Inorganic chemistry.

[26]  A. Salifoglou,et al.  Synthesis, pH-dependent structural characterization, and solution behavior of aqueous aluminum and gallium citrate complexes. , 2001, Inorganic chemistry.

[27]  A. Yoshitake,et al.  A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis , 2001, JBIC Journal of Biological Inorganic Chemistry.

[28]  A. Spek,et al.  Vanadium(IV) and -(V) complexes with O,N-chelating aminophenolate and pyridylalkoxide ligands. , 2000, Inorganic chemistry.

[29]  A. Salifoglou,et al.  Manganese citrate chemistry: syntheses, spectroscopic studies, and structural characterizations of novel mononuclear, water-soluble manganese citrate complexes. , 2000, Inorganic Chemistry.

[30]  E. Baran Oxovanadium(IV) and oxovanadium(V) complexes relevant to biological systems. , 2000, Journal of inorganic biochemistry.

[31]  D. Gefel,et al.  Insulin-like effects of vanadium: basic and clinical implications. , 2000, Journal of inorganic biochemistry.

[32]  H. J. Jakobsen,et al.  Characterization of divalent metal metavanadates by 51V magic-angle spinning NMR spectroscopy of the central and satellite transitions. , 2000, Inorganic chemistry.

[33]  R. Brooks,et al.  Dynamic relaxometry: application to iron uptake by ferritin , 2000, JBIC Journal of Biological Inorganic Chemistry.

[34]  A. Salifoglou,et al.  Synthesis, spectroscopic, and structural characterization of the first aqueous cobalt(II)-citrate complex: toward a potentially bioavailable form of cobalt in biologically relevant fluids , 2000, JBIC Journal of Biological Inorganic Chemistry.

[35]  D. Schomburg,et al.  X-ray structure determination of a vanadium-dependent haloperoxidase from Ascophyllum nodosum at 2.0 A resolution. , 1999, Journal of molecular biology.

[36]  J. McNeill,et al.  Vanadyl-biguanide complexes as potential synergistic insulin mimics. , 1999, Journal of inorganic biochemistry.

[37]  F. Hamel,et al.  Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats. , 1999, International journal of pharmaceutics.

[38]  A. Butler Mechanistic considerations of the vanadium haloperoxidases , 1999 .

[39]  A. Salifoglou,et al.  Synthesis, Structural Characterization, and Solution Behavior of the First Mononuclear, Aqueous Aluminum Citrate Complex , 1999 .

[40]  A. Salifoglou,et al.  Synthesis, Spectroscopic and Structural Characterization of the First Mononuclear, Water Soluble Iron−Citrate Complex, (NH4)5Fe(C6H4O7)2·2H2O , 1998 .

[41]  B. Varghese,et al.  Magneto-Structural Correlation Studies of A Ferromagnetically Coupled Dinuclear Vanadium(IV) Complex. Single-Crystal EPR Study. , 1998, Inorganic chemistry.

[42]  J. Marek,et al.  Synthesis, characterization and crystal structure of a stable aqua-dioxo-tetraperoxodivanadate(V) with a cation of macrocyclic tetraamine , 1997 .

[43]  P G Drake,et al.  A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. , 1996, Endocrinology.

[44]  H. Ratajczak,et al.  Polarized vibrational spectra of betaine monohydrate single crystal , 1996 .

[45]  M. Battell,et al.  Vanadium compounds as insulin mimics. , 1999, Metal ions in biological systems.

[46]  W. M. Davis,et al.  A Unique Coordination Mode for Citrate and a Transition Metal: K2[V(O)2(C6H6O7)]2.cntdot.4H2O , 1995 .

[47]  万惠霖,et al.  Synthesis and crystal structure of sodium ammonium dimeric (citrato)dioxovanadium(V) Na_2(NH_4)_4[VO_2(cit)]_2·6H_2O , 1995 .

[48]  F. Pavelčík,et al.  Synthesis, Vibrational Spectra, and Single-Crystal X-ray Structure of the Phosphato-Bridged Dinuclear Peroxovanadate (NH4)5[V2O2(O2)4PO4].cntdot.H2O , 1995 .

[49]  Steven O. Smith,et al.  Ramped-Amplitude Cross Polarization in Magic-Angle-Spinning NMR , 1994 .

[50]  J. Zubieta Clusters and Solid Phases of the Oxovanadium–Phosphate and – Organophosphonate Systems , 1994 .

[51]  S. Fricker Metal Compounds in Cancer Therapy , 1994, Springer Netherlands.

[52]  J. Dixon,et al.  Protein tyrosine phosphatases. , 2010, Annual review of biochemistry.

[53]  J. Zubieta,et al.  Synthesis and structural characterization of binuclear vanadium-oxo-organophosphonato complexes: building blocks for oxovanadium organophosphonate solids , 1993 .

[54]  B. Posner,et al.  Insulin mimetic peroxovanadium complexes: preparation and structure of potassium oxodiperoxo(pyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(C5H4NCOO)].2H2O, and potassium oxodiperoxo(3-hydroxypyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(OHC5H3NCOO)].3H2O, and their reactions with cysteine , 1993 .

[55]  R. Wever,et al.  The chloroperoxidase from the fungus Curvularia inaequalis; a novel vanadium enzyme. , 1993, Biochimica et biophysica acta.

[56]  M. Bhattacharjee,et al.  Synthesis and physico-chemical studies of newer mono and diperoxo heteroligand complexes of vanadium , 1992 .

[57]  M. Julve,et al.  Crystal structure and magnetic properties of bis(isothiocyanato)bis(pyrazine)iron polymer, a 2D sheetlike polymer , 1991 .

[58]  T. Mak,et al.  Metal-betaine interactions VII. Crystal and molecular structures of aquadichloro(pyridine betaine)zinc(II), dichlorobis(pyridine betaine)zinc(II) and dichlorobis(betaine)zinc(II) monohydrate , 1991 .

[59]  D. Rehder The Bioinorganic Chemistry of Vanadium , 1991 .

[60]  Xiao‐Ming Chen,et al.  Metal-betaine interactions. I. Crystal structure of polymeric trans-diaquabis(pyridine betaine)manganese(II) dichloride , 1991 .

[61]  Xm Chen,et al.  Metal-Betaine Interactions.XIV. Silver(I) 3-Carboxylato-1-pyridinioacetate Monohydrate, [Ag{C5H4(COO)NCH2.COO}]n.nH2O , 1991 .

[62]  Xiao‐Ming Chen,et al.  Metal-betaine interactions—VI. Crystal and molecular structure of tetrakis(betaine)copper(II) nitrate, [Cu(Me3NCH2COO)4](NO3)2 , 1991 .

[63]  Xiao‐Ming Chen,et al.  Metal–betaine interactions. Part 13. Preparation and crystal structures of four polymeric silver(I) complexes of betaine derivatives , 1991 .

[64]  R. Burris,et al.  Citrate substitutes for homocitrate in nitrogenase of a nifV mutant of Klebsiella pneumoniae. , 1990, Biochemistry.

[65]  M. Bhattacharjee,et al.  Synthesis, characterisation and physicochemical properties of peroxo-vanadium(V) complexes with glycine as the hetero-ligand , 1990 .

[66]  M. Pisárčik,et al.  Raman spectral study on the structure of vanadium(V) oxodiperoxo complexes in aqueous solution , 1990 .

[67]  J.J.R. Frausto da Silva Vanadium in biology—the case of the Amanita toadstools , 1989 .

[68]  M. Lee,et al.  Towards a model for vanadium(V) in proteins , 1989 .

[69]  E. Sinn,et al.  Oxoperoxo(citrato)- and dioxo(citrato)vanadates(V): synthesis, spectra, and structure of a hydroxyl oxygen bridged dimer K2[VO(O2)(C6H6O7)]2.2H2O , 1989 .

[70]  W. Griffith,et al.  Studies on transition metal peroxo complexes—X. The nature of peroxovanadates in aqueous solution , 1989 .

[71]  K. Lau,et al.  Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.

[72]  K. Volka,et al.  Correlation between stretching mode absorptions and asymmetry of the V(O2) group in peroxo complexes of vanadium(V) , 1988 .

[73]  G. Wampler,et al.  Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium. , 1985, Journal of inorganic biochemistry.

[74]  J. Klarlund Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins , 1985, Cell.

[75]  T. Mak,et al.  Synthesis and characterization of a 3:2 complex of copper(II) azide with 2-benzoylpyridine: a polymeric structure containing an end-on triply bridging azido ligand , 1985 .

[76]  W. Brill,et al.  Die Kristallstruktur der Hochtemperaturphase von Betaincalciumchlorid-Dihydrat, (CH3)3NCH2COO•CaCl2•2H2O , 1985 .

[77]  D. Rosseinsky Reactant approach: the spherical shell model for molecular juxtaposition , 1984 .

[78]  R. Seip,et al.  The Crystal Structure of 2,2'-Bipyridinium(1+) mu-Hydrogen-bis[(2,2'-bipyridine)oxodiperoxovanadate](1-)-x-hydrogen peroxide-(6-x)-water, (Hbipy)[H{VO(O2)2bipy}2].xH2O2.(6-x)H2O, x ~= 0.5, at -100 degrees C. , 1984 .

[79]  H. Ohtaki,et al.  The Crystal Structure of Ammonium mu-Oxo-bis(oxodiperoxovanadate)(4--), (NH4)4[O{VO(O2)2}2]. A Refinement. , 1984 .

[80]  J. Smith,et al.  Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Y. Yukawa,et al.  Structure and Properties of Dichloro(L-proline)cadmium(II) Hydrate , 1983 .

[82]  J. Fischer,et al.  Vanadium(V) peroxy complexes. New versatile biomimetic reagents for epoxidation of olefins and hydroxylation of alkanes and aromatic hydrocarbons , 1983 .

[83]  U. Wahlgren,et al.  The Crystal Structure of (2,2'-Bipyridine)oxoperoxo(pyridine-2-carboxylato)vanadium(V) Hydrate, [VO(O2)(C5H4NCOO)(C10H8N2)].H2O at -100 degrees C. , 1983 .

[84]  H. Köpf,et al.  Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect. , 1981, European journal of cancer.

[85]  Glen B. Deacon,et al.  Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination , 1980 .

[86]  H. Gray,et al.  Electron transfer in metal-dioxygen adducts , 1980 .

[87]  H. Gray,et al.  Electronic spectra of metal-dioxygen complexes , 1978 .

[88]  G. Marongiu,et al.  Unusual mode of coordination of bis(2-aminoethyl)amine in catena-bis[.mu.-bis(2-aminoethyl)amine]-bis(.mu.-thiocyanato)bis(isothiocyanato)dicadmium(II) , 1977 .

[89]  M. Drew,et al.  Seven-co-ordination in metal complexes of quinquedentate macrocyclic ligands. Part 7. Synthesis and properties of some manganese(II), iron(III), iron(II), zinc(II), and cadmium(II) complexes of an N3O2 macrocycle and the crystal and molecular structure of {2,13-dimethyl-6,9-dioxa-3,12,18-triazabicyc , 1977 .

[90]  L. Pazdernik,et al.  Bispyridine adduct of cobalt(II) mercury(II) tetrathiocyanate , 1976 .

[91]  T. M. Brown,et al.  Crystal and molecular structure of tetraisothiocyanatobis(2,2'-bipyridine)niobium(IV) and -zirconium(IV) , 1976 .

[92]  G. Marongiu,et al.  Five-co-ordinate cadmium(II) in [bis(2-dimethylaminoethyl)methylamine]di-isothiocyanatocadmium(II) , 1976 .

[93]  N. Vuletić,et al.  Oxodiperoxovanadate(V) complexes with bidentate ligands , 1973 .

[94]  L. Ehrenberg,et al.  Studies on Peroxovanadates. I. The Crystal Structure of Ammonium mu-Oxo-bis(oxodiperoxovanadate(V)), (NH4)4[O(VO(O2)2)2]. , 1971 .

[95]  S. Westman,et al.  The Crystal Structure of Diazidodipyridinecadmium [Cd(N3)2(C5H5N)2]. , 1970 .

[96]  W. Griffith,et al.  Studies on transition-metal peroxy-complexes. Part VI. Vibrational spectra and structure , 1968 .

[97]  J. Yoe Inorganic Thermogravimetric Analysis, Second and Revised Edition. , 1963 .

[98]  E. Lippincott,et al.  The Infrared Spectra of Some Amino Acids , 1957 .

[99]  D. F. Evans 796. Blue perchromic acid , 1957 .